GleamWall
中文EN

SIBN SI-BONE, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1459839 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.0%
TTM net income YoY37.1%
TTM EPS YoY39.2%
Revenue 3-yr CAGR18.7%
Net income 3-yr CAGR—

Margins

Gross margin79.4%
Operating margin-7.6%
Net margin-6.2%
FCF margin-1.9%
EBITDA margin-4.6%

Returns

ROE-7.7%
ROA-5.6%
ROIC (approx.)-7.2%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets28.1%
Debt / equity0.19x
Current ratio7.58x
Interest coverage-6.88x

Cash quality & payout

Operating cash flow / net income-0.44x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$55.70M$56.01M$52.59M$56.35M$48.66M$48.63M$47.29M$49.00M
Cost of revenue$11.54M$11.46M$10.64M$11.82M$9.81M$9.82M$9.60M$10.22M
Gross profit$44.17M$44.55M$41.94M$44.53M$38.85M$38.81M$37.70M$38.78M
R&D expense$4.56M$5.22M$4.19M$4.36M$4.24M$4.31M$4.53M$3.87M
SG&A expense$10.11M$10.11M$10.04M$9.82M$10.03M$10.72M$9.96M$9.15M
Operating income-$4.35M-$4.81M-$5.09M-$2.46M-$5.38M-$7.00M-$7.48M-$5.49M
Interest expense$608,000$598,000$592,000$630,000$670,000$666,000$662,000$793,000
Income tax$0$0$0$0$0$0$0$0
Net income-$3.62M-$4.09M-$4.33M-$1.64M-$4.57M-$6.15M-$6.54M-$4.50M
EBITDA-$2.65M-$3.11M-$3.48M-$825,000-$3.88M-$5.60M-$6.20M-$4.28M
EPS (basic)-0.08-0.09-0.10—-0.11-0.14-0.15—
EPS (diluted)-0.08-0.09-0.10—-0.11-0.14-0.15—
Weighted avg. shares (diluted)44.90M44.48M43.96M—43.19M42.79M42.34M—
Balance sheet
Cash & equivalents$35.31M$33.13M$33.53M$42.24M$26.49M$34.15M$41.19M$34.95M
Receivables$31.47M$31.18M$30.96M$29.91M$26.53M$24.37M$26.70M$27.46M
Inventory$42.35M$38.39M$35.53M$33.90M$35.73M$34.24M$30.38M$27.07M
Current assets$224.65M$219.91M$214.72M$216.12M$210.78M$207.45M$204.20M$207.78M
PP&E, net$25.30M$21.72M$20.45M$21.30M$21.93M$21.70M$21.07M$20.37M
Total assets$256.77M$248.76M$242.72M$238.56M$234.27M$230.92M$227.28M$230.44M
Current liabilities$29.62M$24.04M$21.49M$25.28M$26.44M$24.75M$23.95M$27.13M
Long-term debt$35.66M$35.63M$35.60M$35.57M$35.54M$35.51M$35.48M$35.45M
Total debt$35.66M$35.63M$35.60M$35.57M$35.54M$35.51M$35.48M$35.45M
Total liabilities$72.09M$66.41M$63.78M$61.02M$62.15M$60.58M$60.02M$63.47M
Shareholders' equity$184.68M$182.35M$178.94M$177.53M$172.13M$170.34M$167.26M$166.96M
Net debt$346,000$2.50M$2.06M-$6.67M$9.05M$1.36M-$5.71M$504,000
Shares outstanding45.00M44.70M44.20M43.65M43.27M43.01M42.48M42.09M
Cash flow statement
Operating cash flow$5.94M$777,000-$2.36M$1.73M$2.33M$173,000-$4.91M$1.18M
Capital expenditure$6.37M$1.54M$1.08M$1.29M$2.96M$2.10M$2.07M$2.27M
Free cash flow-$427,000-$768,000-$3.44M$440,000-$620,000-$1.93M-$6.98M-$1.09M
Investing cash flow-$4.08M-$2.74M-$6.23M$13.03M-$10.03M-$9.47M$10.63M$4.34M
Financing cash flow$347,000$1.63M$34,000$1.03M$11,000$2.23M$103,000-$78,000
Depreciation & amortization$1.70M$1.70M$1.62M$1.64M$1.50M$1.40M$1.28M$1.21M
Stock-based compensation$5.71M$5.98M$6.03M$5.98M$6.23M$6.66M$6.66M$6.13M

Free plan shows the latest 8 periods; Pro shows all 37 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.